Amgen is said to agree to buy horizon at $26 billion valuation
The US biotechnology giant offered around $116.5 for each Horizon share, said the person, who asked not to be identified as the information is private. The offer price is at a around 20% premium to Horizonâs closing price of $97.29 on Friday.